B. Riley Wealth Advisors Inc. Has $936,000 Stake in Humana Inc. (NYSE:HUM)

B. Riley Wealth Advisors Inc. raised its position in shares of Humana Inc. (NYSE:HUMFree Report) by 15.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,041 shares of the insurance provider’s stock after purchasing an additional 278 shares during the period. B. Riley Wealth Advisors Inc.’s holdings in Humana were worth $936,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Barlow Wealth Partners Inc. acquired a new position in Humana during the fourth quarter valued at approximately $1,977,000. Auxano Advisors LLC acquired a new position in Humana during the fourth quarter valued at approximately $540,000. Intech Investment Management LLC raised its position in Humana by 46.2% during the fourth quarter. Intech Investment Management LLC now owns 42,287 shares of the insurance provider’s stock valued at $19,359,000 after purchasing an additional 13,356 shares in the last quarter. AdvisorShares Investments LLC acquired a new position in Humana during the fourth quarter valued at approximately $421,000. Finally, Mariner LLC raised its position in Humana by 2.3% during the third quarter. Mariner LLC now owns 14,119 shares of the insurance provider’s stock valued at $6,869,000 after purchasing an additional 312 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several brokerages have commented on HUM. Oppenheimer lowered their price objective on shares of Humana from $415.00 to $370.00 and set an “outperform” rating for the company in a research report on Thursday, April 25th. Jefferies Financial Group lowered their price target on shares of Humana from $411.00 to $381.00 and set a “buy” rating for the company in a report on Monday, April 22nd. Raymond James started coverage on shares of Humana in a report on Friday, March 22nd. They set a “market perform” rating for the company. Royal Bank of Canada lowered their price target on shares of Humana from $415.00 to $353.00 and set an “outperform” rating for the company in a report on Thursday, April 25th. Finally, Argus downgraded shares of Humana from a “buy” rating to a “hold” rating in a report on Wednesday, March 13th. Thirteen investment analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $423.63.

Read Our Latest Stock Report on Humana

Humana Stock Performance

Shares of HUM opened at $357.42 on Friday. The company has a current ratio of 1.67, a quick ratio of 1.67 and a debt-to-equity ratio of 0.77. The stock has a market capitalization of $43.07 billion, a P/E ratio of 22.26, a price-to-earnings-growth ratio of 2.05 and a beta of 0.53. The firm’s fifty day simple moving average is $339.29 and its two-hundred day simple moving average is $356.17. Humana Inc. has a 12 month low of $298.61 and a 12 month high of $530.54.

Humana (NYSE:HUMGet Free Report) last issued its quarterly earnings results on Wednesday, April 24th. The insurance provider reported $7.23 EPS for the quarter, beating analysts’ consensus estimates of $6.12 by $1.11. The business had revenue of $29.61 billion for the quarter, compared to analysts’ expectations of $28.52 billion. Humana had a net margin of 1.82% and a return on equity of 17.76%. The business’s quarterly revenue was up 10.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $9.38 earnings per share. As a group, analysts predict that Humana Inc. will post 16.07 EPS for the current year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, June 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.99%. Humana’s dividend payout ratio (DPR) is presently 22.04%.

About Humana

(Free Report)

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Featured Stories

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUMFree Report).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.